Nanalysis Revenue and Competitors

Calgary, AB CAN

Location

$28.3M

Total Funding

Electronics

Industry

Estimated Revenue & Valuation

  • Nanalysis's estimated annual revenue is currently $14.3M per year.(i)
  • Nanalysis's estimated revenue per employee is $242,052
  • Nanalysis's total funding is $28.3M.

Employee Data

  • Nanalysis has 59 Employees.(i)
  • Nanalysis grew their employee count by -16% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$47.7M17712%N/AN/A
#2
$13M597%N/AN/A
#3
$14.3M59-16%$28.3MN/A
#4
$18.6M7621%N/AN/A
#5
$13M6113%$17.7MN/A
#6
$1.5M10150%N/AN/A
#7
$265.1M77338%N/AN/A
#8
$8.6M445%N/AN/A
#9
$9.2M474%N/AN/A
#10
$7.6M39N/AN/AN/A
Add Company

Nanalysis Scientific Corp. is a public company (TSXV:NSCI, FRA:1N1, OTCMKTS:NSCIF). The company is a global manufacturer and seller of compact Nuclear Magnetic Resonance (NMR) spectrometers. The NMReady-60ᅢᄁ¬ダᅡᄁ was the first portable, high-resolution 60 MHz benchtop NMR spectrometer released in the market in 2013. These instruments are notable for their ease of use, low-maintenance, accessibility, affordability and automatability. In 2019, Nanalysis introduced the 100 MHz spectrometer, representing the highest resolution instrument available on the market. Designed with flexibility in mind, the instruments can be configured as traditional NMR spectrometers or programmed as analyzers for specific industrial applications (oil and gas, chemical, pharma, biotech, food science, atomic agencies, cannabis, mining). The company has sold instruments in over 45 countries and is expanding our North American sales team. Nanalysis' benchtop NMR technology has been widely recognized, including being named Company of the Year in Global Portable NMR in the prestigious Frost & Sullivan award for three consecutive years. In 2020 Nanalysis expanded its portfolio of magnetic resonance technology acquiring RS2D and their superior camelon 4 technology offering their high-field NMR pulse console (200-600MHz), preclinical MRI and MRI product line.

keywords:N/A

$28.3M

Total Funding

59

Number of Employees

$14.3M

Revenue (est)

-16%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Nanalysis News

2022-04-17 - Nanalysis Announces Fourth Quarter and Full Year 2021 Conference Call

Nanalysis logo (CNW Group/Nanalysis Scientific Corp.) Investors interested in participating on the live call can...

2022-04-06 - Nanalysis Scientific Corp. to Present at NobleCon18

Nanalysis devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law...

2022-04-06 - /C O R R E C T I O N from Source -- Nanalysis Scientific Corp./

/C O R R E C T I O N from Source -- Nanalysis Scientific Corp./. April 13, 2022 ·4 min read. In this article: NSCIF. Recommendation Rating.

2021-08-25 - Nanalysis Scientific Corp. : Closes Bought Deal Public Offering and Concurrent Non-Brokered Private Placement for Gross Proceeds of C$10,997,686

CALGARY, AB, Aug. 25, 2021 /CNW/ - Nanalysis Scientific Corp. Nanalysis Scientific Corp. ("the Company"), (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), announces it has closed the previously-announced underwritten public offering (the "Public Offering") of units (the "Units") of the Company and the co ...

2021-07-29 - Nanalysis Scientific Corp. : Announces $8 Million "Bought Deal" Public Offering

/NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES/ CALGARY, AB, July 29, 2021 /CNW/ - (the "Company" or "Nanalysis"), (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) is pleased to announce that it has entered into an agreement with a syndicate of underwriters led by Ec ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$13M597%N/A
#2
N/A5948%N/A
#3
$11.7M599%N/A
#4
$7.7M59N/AN/A
#5
$11.9M60-5%N/A